• Explore /
  • Poster
  • / Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).

Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).

Abstract Poster

Authors

null

Francis Levi

Medical Oncology Department, INSERM U776, Paul Brousse Hospital, Villejuif, France

Francis Levi , Abdoulaye Karaboué , Raphaël Saffroy , Elodie Peyric , Michel Ducreux , Denis Michel Smith , Mohamed Hebbar , Pasquale F. Innominato , Simon Pernot , Carlos Carvalho , Rosine Guimbaud , C. N. J. Focan , Mohamed Bouchahda , Rene Adam , Marie-Christine Etienne-Grimaldi , Gerard A. Milano , Antoinette Lemoine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00852228

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3593)

DOI

10.1200/jco.2014.32.15_suppl.3593

Abstract #

3593

Poster Bd #

56

Abstract Disclosures

Similar Posters

First Author: Francis Levi

First Author: Patrick M Boland

First Author: Evelyne Lopez-Crapez

First Author: Francis Levi